FAFGX | PGBEX | FAFGX / PGBEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 9 years | - |
Gain YTD | 3.391 | 2.027 | 167% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 307B | 11.7B | 2,624% |
Annual Yield % from dividends | 0.69 | 0.00 | - |
Returns for 1 year | 22.60 | 17.59 | 129% |
Returns for 3 years | 13.99 | 23.35 | 60% |
Returns for 5 years | N/A | 60.80 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EVUS | 29.69 | 0.17 | +0.59% |
iShares ESG Aware MSCI USA Value ETF | |||
HYHG | 66.17 | 0.18 | +0.27% |
ProShares High Yield—Interest Rate Hdgd | |||
SGOL | 25.77 | -0.15 | -0.58% |
abrdn Physical Gold Shares ETF | |||
GDXD | 13.29 | -0.16 | -1.19% |
MicroSectors™ Gold Mns 3X Inv Lvrgd ETN | |||
PPH | 85.31 | -1.17 | -1.35% |
VanEck Pharmaceutical ETF |